Group B Streptococcus Antigens

Details for Australian Patent Application No. 2007202175 (hide)

Owner ID Biomedical Corporation

Inventors Hamel, Josee; Boyer, Martine; Charlebois, Isabelle; Brodeur, Bernard R.; Martin, Denis; Rioux, Clement

Agent Cullens

Pub. Number AU-B-2007202175

Parent 2007200130

Filing date 15 May 2007

Wipo publication date 7 June 2007

Acceptance publication date 15 July 2010

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

31 May 2007 Complete Application Filed

7 June 2007 Application Open to Public Inspection

  Published as AU-B-2007202175

15 July 2010 Application Accepted

  Published as AU-B-2007202175

11 November 2010 Standard Patent Sealed

9 August 2012 Application for Amendment

  The nature of the amendment is: Amend the patentee name to read ID Biomedical Corporation of Quebec . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

23 August 2012 Alteration of Name

  The name of the patentee has been altered to ID Biomedical Corporation of Quebec

6 September 2012 Assignment Registered

  ID Biomedical Corporation The patent has been assigned to ID Biomedical Corporation of Quebec Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202176-Cytotoxic T Lymphocytes Activated by Dendritic Cell Hybrids

2007202174-Facing material with controlled porosity for construction boards